SCHEMBL15025473

SCHEMBL15025473

CNc1ccccc1CNC1CCNCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.50
SLC6A4 P31645 2/20 0.50
SLC6A3 Q01959 1/20 0.50
TACR1 P25103 1/20 0.44
SOS1 Q07889 1/20 0.44
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM1A O60341 5/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
EP300 Q09472 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
MAOA P21397 1/20 0.36
HRH1 P35367 1/20 0.36
BCHE P06276 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16313693 0.85 SOS1 (0.49) SLC6A2SLC6A4SLC6A3TACR1SOS1
SCHEMBL1143633 0.84 KDM4E (0.58) TACR1KDM4EPKMLMNAHTT
Hydrochloric Acid SCHEMBL5154366 0.83 KDM4E (0.56) TACR1KDM4EPKMLMNAHTT
SCHEMBL14498225 0.81 KDM4E (0.53) SLC6A2SLC6A4SLC6A3SOS1KDM4E
SCHEMBL27978884 0.81 SLC6A4 (0.52) SLC6A2SLC6A4SLC6A3SOS1LMNA
SCHEMBL15025562 0.80 TACR1 (0.49) TACR1KDM4EPKMKMT2AMEN1
SCHEMBL14498226 0.80 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3SOS1KDM4E
SCHEMBL70402 0.78 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3SOS1LMNA
SCHEMBL2779198 0.78 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3TACR1SOS1
SCHEMBL28954715 0.78 GBA1 (0.51) SLC6A4KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013083741-A1 1,2,4 -TRIAZOLES AS ALLOSTERIC MODULATORS OF MGLU5 RECEPTOR ACTIVITY FOR THE TREATMENT OF SCHIZOPHRENIA OF DEMENTIA BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-06-13 WO disclosed